Statistics
Publications
9
Citations
1.5K
H-Index
9
Active since
2014
Brian Diskin is an author at New York University specializing in oncology, cancer immunotherapy, and tumor immunology.
Publications per year
2014–2025
9
9
SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models
Carmine Fedele, Hao Ran, Brian Diskin et al. · Cancer Discovery · 2018 · 315 citations · Full text
Medicine, Oncology, Pharmacology +17
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
Wei Wang, Jill M. Marinis, Allison M. Beal et al. · Cancer Cell · 2018 · 250 citations · Full text
Life Sciences, Immunology, Oncology +16
1–5 of 9